A Novel 5-Chloro-N-Phenyl-1 H-Indole-2-carboxamide Derivative as a Glycogen Phosphorylase Inhibitor: Evaluating the Long-Term Drug Effects on Muscle Function for the First Time
Molecules · 2024
DOI: 10.3390/molecules29184448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Yifan Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Traditional Chinese Medicine Research and Development of Hebei Province, Institute of Traditional Chinese Medicine, Chengde Medical Uni…. Hauptthemen laut MEDLINE: Glycogen Phosphorylase, Glycogen, Muscle, Skeletal. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, open project supported by Hebei Province Key Laboratory of Traditional Chinese Medicine Research and Development, Hebei Province Key Laboratory of Traditional Chinese Medicine Research and Development.
Abstract (Originalsprache)
Compound 1 was previously identified by our team as a glycogen phosphorylase (GP) inhibitor with glucose-lowering activity and demonstrated to have protective effects against myocardial and cerebral ischemia. However, its impact on muscle function has not been clarified. This study is the first to evaluate the long-term effects of GP inhibitors on muscle function and metabolism. After a 28-day administration of Compound 1, we performed assays to assess muscle function and biochemical parameters in rats. We observed reductions in peak holding force, duration, tetanic contraction force, single-contraction force, and electromyographic signals under 20 s and 10 min contraction stimuli. The metabolic analysis showed no significant effects on muscle glycogen, ATP, lactic acid, and uric acid levels at low doses. In contrast, medium to high doses resulted in increased glycogen, decreased ATP, and reduced lactic acid (only at high doses), without affecting uric acid. These findings suggest that Compound 1 may adversely affect muscle function in rats, potentially due to the glycogen inhibition effects of GP inhibitors. This study provides crucial safety data and insights into the long-term effects of GP inhibitors on rat muscles, which will guide future developments and applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Traditional Chinese Medicine Research and Development of Hebei Province, Institute of Traditional Chinese Medicine, Chengde Medical University, Chengde 067000, China.
- Department of Pathogen Biology, Chengde Medical University, Chengde 067000, China.
ORCID-Profile: Youde Wang
Förderung
- Natural Science Foundation of Hebei Province
- open project supported by Hebei Province Key Laboratory of Traditional Chinese Medicine Research and Development
- Hebei Province Key Laboratory of Traditional Chinese Medicine Research and Development
Zitieren
APA
Zhao, Y., Yan, Z., Li, S., Wang, Y., Guo, Y., Wang, T., & Zhang, L. (2024). A Novel 5-Chloro-N-Phenyl-1 H-Indole-2-carboxamide Derivative as a Glycogen Phosphorylase Inhibitor: Evaluating the Long-Term Drug Effects on Muscle Function for the First Time. Molecules. https://doi.org/10.3390/molecules29184448
Vancouver
Zhao Y, Yan Z, Li S, Wang Y, Guo Y, Wang T, et al. A Novel 5-Chloro-N-Phenyl-1 H-Indole-2-carboxamide Derivative as a Glycogen Phosphorylase Inhibitor: Evaluating the Long-Term Drug Effects on Muscle Function for the First Time. Molecules. 2024. doi:10.3390/molecules29184448
BibTeX
@article{Zhao2024,
author = {Zhao, Yifan and Yan, Zhiwei and Li, Shuai and Wang, Youde and Guo, Yachun and Wang, Tienan and Zhang, Liying},
title = {A Novel 5-Chloro-N-Phenyl-1 H-Indole-2-carboxamide Derivative as a Glycogen Phosphorylase Inhibitor: Evaluating the Long-Term Drug Effects on Muscle Function for the First Time},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29184448}
}
EUVIMED